schizandrin has been researched along with lignans in 181 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (9.39) | 18.7374 |
| 1990's | 16 (8.84) | 18.2507 |
| 2000's | 35 (19.34) | 29.6817 |
| 2010's | 84 (46.41) | 24.3611 |
| 2020's | 29 (16.02) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeya, Y; Kobayashi, H; Taguchi, H; Yosioka, I | 1 |
| He, J; Liu, Y; Sha, D; Wang, L; Zheng, S | 1 |
| Cui, YY; Wang, MZ | 1 |
| Li, XY | 1 |
| Niu, X; Zhang, L | 1 |
| Lin, TJ | 1 |
| Jia, WY; Li, XJ; Liu, GT; Xin, WJ; Zhao, BL | 1 |
| Li, XJ; Liu, GT; Xin, WJ; Zhao, BL | 1 |
| Song, WZ; Tong, YY; Wang, K | 1 |
| Liu, GT | 2 |
| Rao, WW | 1 |
| Liu, GT; Wei, HL | 1 |
| Long, ZZ; Xie, SS | 1 |
| Li, M | 1 |
| Long, ZZ | 1 |
| Bian, ZJ; Niu, XY; Ren, ZH | 1 |
| Bian, ZJ; Niu, XY; Ren, ZH; Wang, WJ | 1 |
| Cresteil, T; Le Provost, E; Lesca, P; Liu, KT | 1 |
| Lesca, P; Liu, KT | 2 |
| Aburada, M; Harada, M; Ikeya, Y; Maeda, S; Miyamoto, Y; Shinbo, M; Sudo, K; Taguchi, H; Takeda, S | 1 |
| Gu, KJ; Tang, CF; Xi, GL; Zhang, HL | 1 |
| Aburada, M; Harada, M; Ikeya, Y; Maeda, S; Sudo, K; Taguchi, H; Yoshioka, I | 1 |
| Ikeya, Y; Maruno, M; Ono, H; Oyama, T; Sugama, K; Takeda, S; Tanaka, M; Wakamatsu, T | 1 |
| Amagaya, S; Ikeya, Y; Maruno, M; Matsuzaki, Y; Ono, H; Takeda, S; Wakui, Y | 1 |
| Ahn, KS; Jung, KY; Lee, HK; Lee, IS; Oh, SR; Park, SH | 1 |
| Che, CT; Ip, SP; Ko, KM | 1 |
| Chin, YW; Choi, YH; Jang, YP; Joung, SN; Kim, J; Kim, JY; Kim, Y; Kim, YC; Noh, MJ; Yoo, KP | 1 |
| Li, RC; Lin, KF; Yeung, RY; Zhu, M | 1 |
| Choi, SJ; Jeong, CK; Kim, SB; Ko, GI; Lee, HS; Sohn, DH | 1 |
| Coleman, RS; Guernon, JM; Roland, JT | 1 |
| Guo, J; Lu, Q; Sun, X; Wei, X; Yao, Z; Zhang, D; Zhang, X; Zhang, Z | 1 |
| Hsieh, MT; Lin, LW; Wang, WH; Wu, CR | 1 |
| Havlícková, P; Krenková, M; Opletal, L | 2 |
| Chang, J; Xie, J | 1 |
| Gu, ZB; Han, GX; Wang, LX; Zhang, WD | 1 |
| George, KM; Molander, GA; Monovich, LG | 1 |
| Kim, SH; Kim, SR; Kim, YC; Koo, KA; Lee, MK; Lee, NG; Markelonis, GJ; Oh, TH; Sung, SH; Yang, JH | 1 |
| Pan, WJ; Xiao, X; Xiao, XH; Yuan, HL; Zhao, YL | 1 |
| Li, JQ; Li, P; Mu, J; Zhang, LQ; Zhu, XL | 1 |
| Fan, G; Peng, J; Qu, L; Wu, Y; Zhou, X | 1 |
| Li, H; Li, X; Wang, G; Wang, R; Wang, W; Xie, H; Xu, M; Yue, L; Zhu, D | 1 |
| Gao, Q; Li, XG; Luo, HM; Weng, W | 1 |
| Yan, YQ; Yu, BY; Yue, L; Zhu, DN | 1 |
| Konishi, T; Kushida, M; Nakajima, Y; Nishida, H; Ogawa, Y; Sato, S; Tatewaki, N | 1 |
| Bae, EA; Bae, KH; Kim, DH; Lee, B; Phuong, TT; Shin, YW; Trinh, HT | 1 |
| Egashira, N; Fujiwara, M; Iwasaki, K; Kurauchi, K; Mishima, K; Oishi, R; Orito, K | 1 |
| Huang, Q; Jia, YW; Wang, GJ; Xie, HT; Xu, MJ | 1 |
| Fujii, M; Hou, DX; Lin, S | 1 |
| Huang, Q; Jia, Y; Wang, G; Wang, W; Xie, H; Xu, M | 1 |
| Huang, M; Jin, J; Liu, GT; Sun, H | 1 |
| Chen, M; Dong, L; Huang, C; Li, L; Liao, Z; Xu, X | 1 |
| Cheng, HY; Hsieh, CC; Hsieh, MT; Li, WC; Lin, YT; Lu, TC; Peng, WH; Tsai, FH; Wu, CR | 1 |
| Chen, M; Liao, Z; Ma, W; Sun, M; Wen, Y; Xu, X; Zhang, H | 1 |
| Bae, KH; Guo, LY; Hong, YN; Hung, TM; Kang, SS; Kim, HP; Kim, YS; Shin, EM; Zhou, HY | 1 |
| Billinsky, JL; Krol, ES | 1 |
| Caichompoo, W; Gao, HJ; Hou, TT; Qin, LP; Zhang, QY; Zhou, XJ | 1 |
| Huang, X; Liu, SY; Liu, ZQ; Song, FR | 1 |
| Gao, XM; He, F; Huang, SX; Lu, Y; Pu, JX; Sun, HD; Wang, RR; Xiao, WL; Zheng, QT; Zheng, YT; Zhong, JL | 1 |
| Gu, P; Hu, LP; Li, J; Lu, B; Shao, JQ; Sun, LJ; Wang, GH; Wang, J; Wang, Q; Wang, YT; Wu, B | 1 |
| Bae, H; Hong, M; Jung, SK; Kim, J; Kim, Y; Lee, H; Oh, BG; Shin, M | 1 |
| Bae, K; Chung, JW; Guo, LY; Hung, TM; Jang, S; Kang, SS; Kim, HP; Kim, YS; Shin, EM | 1 |
| Bae, K; Kang, SS; Kim, SJ; Kim, YS; Lee, EJ; Lee, SK; Min, HY | 1 |
| Chen, J; Xiang, Q; Yang, X | 1 |
| Ji, H; Liu, H; Liu, Y; Shao, B; Tang, J; Wu, L; Zhu, D | 2 |
| Cao, YF; Fang, ZZ; Ge, GB; Hu, D; Huang, T; Huo, H; Li, J; Liu, HX; Sun, DX; Wang, YC; Yang, L; Yin, J; Zhang, YY | 1 |
| Huang, X; Huang, YJ; Li, YB; Wang, Q; Xiao, XH; Yuan, HL | 1 |
| Chen, W; Gao, S; Sun, L; Tai, Z; Wei, H; Xu, W | 1 |
| Bauer, R; Blunder, M; Fabian, WM; Hüfner, A; Kunert, O; Pferschy-Wenzig, EM; Saf, R; Schühly, W | 1 |
| Hu, Y; Sun, R; Yu, J; Zhou, J | 1 |
| Ha, H; Lee, H; Lee, JA; Lee, KY; Lee, MY; Lee, NH; Seo, CS; Shin, HK | 1 |
| Lin, X; Shaw, PC; Song, JX; Sze, SC; Tong, Y; Wong, RN; Zhang, YB | 1 |
| EFIMOV, VV; VLASOVA, LN | 1 |
| Chen, CH; Chen, Y; Chen, YC; Jeng, CJ; Wang, SM; Yang, SH | 1 |
| Li, SM; Li, X; Meng, FY; Ruan, HL; Sun, JX; Yu, HY | 1 |
| Liu, TT; Ma, CH; Wang, SY; Yang, L; Zhang, RR; Zu, YG | 1 |
| Che, CT; Ip, PS; Yang, J; Yeung, JH | 1 |
| Guan, M; Li, T; Liu, Y; Sheng, Y; Wang, Y; Yuan, G | 1 |
| Choi, YW; Kim, SG; Kim, Y; Kim, YH; Lee, SJ; Park, DJ; Park, SY; Shon, KJ | 1 |
| Che, CT; Ip, PS; Yang, JM; Yeung, JH | 1 |
| Liu, TT; Ma, CH; Yang, FJ; Yang, L; Zhang, L; Zhang, ZH; Zhao, CJ; Zu, YG | 1 |
| Jeong, SI; Kim, SJ; Kim, SY; Kwon, TH; Yu, KY | 1 |
| An, Y; Chang, Y; Chen, X; Fan, H; Huang, X; Lei, J; Liu, S; Liu, W; Ren, K; Shen, N; Wang, Y; Xu, N | 1 |
| Fan, XH; Guo, WJ; Shao, Q; Zhang, YF | 1 |
| Guan, J; Sun, DY; Zhang, XR; Zhao, Y; Zhu, HY | 1 |
| Chen, PD; Wu, Y; Yin, FZ | 1 |
| Cao, Y; Han, N; He, R; Hu, D; Liu, Z; Miao, L; Yin, J | 1 |
| Jeong, HJ; Kim, HM; Moon, PD | 1 |
| Gao, Q; Liao, MJ; Luo, HM; Xu, X; Zhang, Z; Zhou, X; Zhou, XW | 1 |
| Ko, KM; Pan, SY; Sun, N; Wang, XY; Yu, Q; Yu, ZL; Zhang, Y | 1 |
| Dong, JP; He, FC; Li, SX; Liu, WZ; Su, RQ; Zhao, ZQ | 1 |
| Chao, J; Cheng, HY; Hsieh, MT; Lee, MS; Lin, LW; Peng, WH; Tsai, FS; Yen, JC | 1 |
| Han, Y; Sun, H; Wang, X; Wei, W; Wu, F; Zhang, A | 1 |
| Bi, K; Chen, X; Fan, R; Geng, L; He, B; Jia, Y; Li, Q; Su, D; Wei, B; Zhao, L | 1 |
| Chen, D; Chen, M; Lee, KH; Liao, Z; Morris-Natschke, SL; Xu, B; Xu, X; Yang, P | 1 |
| Chen, H; Huang, ZJ; Lu, TL; Mao, CQ; Song, Y; Sun, Y; Wu, XY; Xu, B; Zhou, Y | 1 |
| Han, Y; Lu, SW; Sun, H; Wang, XJ; Wu, XH; Yan, GL; Zhang, AH | 1 |
| Chen, H; Hu, JP; Li, Y; Sheng, L; Wang, BL | 1 |
| Antoine, MH; Bunel, V; Duez, P; Nortier, J; Stévigny, C | 1 |
| Afanaseva, SV; Baulin, SI; Rogacheva, SM | 1 |
| Cheng, Y; Fan, X; Guo, W; Li, Z; Shao, Q; Zhan, S | 1 |
| Dai, G; Ji, D; Li, L; Lu, T; Mao, C; Sun, Y; Wu, X; Xu, B; Yin, F; Zhou, Y | 1 |
| An, Y; Shi, G; Sun, X; Wu, Q; Wu, X; Zhang, M; Zhang, P | 1 |
| Hu, XL; Liu, ZQ; Pi, ZF; Song, FR; Yu, XL | 1 |
| Cao, G; Cao, Z; Guo, Z; Kou, J; Li, L; Yang, H; Yu, B; Zhou, H | 1 |
| Kou, JP; Li, SX; Lv, YN; Yu, BY; Zhai, KF | 1 |
| Chu, ZY; Tian, L; Wu, LH | 1 |
| Jiang, M; Kang, L; Li, Z; Liu, X; Wang, Y; Xu, L; Zhao, X | 1 |
| Cho, SJ; Choi, MS; Jung, UJ; Kim, HJ; Moon, BS; Park, HJ | 1 |
| Bi, K; Jia, Y; Li, X; Liu, A; Liu, Z; Mao, X; Zhang, C; Zhao, X | 1 |
| Fan, XH; Kang, LY; Li, Z; Zhong, Y; Zhu, JQ | 1 |
| Cao, ZP; Huang, JN; Jiang, ZJ; Li, CH; Wang, CY; Xiao, P; Xie, X; Yang, JF | 1 |
| Park, JH; Yoon, J | 1 |
| An, LP; Chen, M; Dou, ZH; Ju, YF; Luo, L; Miao, YX; Qiao, J | 1 |
| Chen, BP; Huang, GR; Huang, XF; Huang, YQ; Huang, ZS; Mo, XQ; Su, JW; Tang, HY; Wei, HY; Wei, LD; Wu, MH; Yu, WQ; Zhao, LJ; Zhou, XH | 1 |
| Cai, Q; Du, SS; Zheng, LS | 1 |
| Lin, HC; Wang, GL; Zhang, LX; Zhu, HY | 1 |
| Ekiert, H; Kisiel, W; Szewczyk, A; Szopa, A | 1 |
| An, LB; Cui, L; Dong, PP; Fang, ZZ; Gonzalez, FJ; Li, WT; Song, JH; Sun, XY; Wang, LX; Wu, X; Zhang, YY; Zhao, DW | 1 |
| Chen, HL; Kou, JP; Li, DP; Li, F; Tan, YS; Yan, Y; Yu, BY; Zhai, KF | 1 |
| Chen, HL; Kou, JP; Li, F; Lv, YN; Shen, K; Tan, YS; Yu, BY; Zhai, KF | 1 |
| Cai, ZP; Huo, DS; Shao, G; Wang, H; Yang, ZJ; Zhang, M; Zhao, ZY | 1 |
| Fan, X; Kou, J; Li, F; Ma, X; Pang, L; Song, M; Yu, B; Zhang, Y | 1 |
| Han, NR; Jeong, HJ; Kim, HM; Kim, HY; Kim, NR; Moon, PD | 1 |
| Chen, F; Chen, M; Luo, C; Mo, Z; Shen, Q; Song, S; Wei, F; Wei, S | 1 |
| Liu, X; Liu, Y; Wang, Y; Zhang, D; Zhang, W | 1 |
| Chae, HJ; Jang, JB; Jeong, HJ; Kim, HM; Kim, KY; Kim, MH; Lee, JM; Nam, SY; Rah, SY | 1 |
| Cheon, SM; Cho, HY; Ham, SH; Kim, SJ; Ko, SM; Kwon, YD; Lee, YB; Shin, H | 1 |
| Fang, M; Li, R; Shang, J; Wang, S; Wang, Y; Yi, H; Zhang, D; Zhang, L; Zhao, A | 1 |
| Bi, K; He, B; Hu, L; Jia, Y; Wan, S; Xiao, F; Xu, M; Yan, T | 1 |
| Chen, ZX; Liu, MY; Wei, BB; Wei, MJ | 1 |
| Chu, C; Fan, XX; Kou, JP; Li, F; Yu, BY; Zhang, Y | 1 |
| Amujuri, D; Lakshma Nayak, V; Poornima, B; Purushotham, U; Sarma, AVS; Sirisha, K; Siva, B; Suresh Babu, K; Tiwari, AK | 1 |
| Kong, L; Sun, H; Wang, XJ; Wang, XQ; Yu, JB; Zhang, AH; Zhang, QY | 1 |
| Feng, YL; Li, W; Liu, KY; Liu, YL; Song, YG; Su, D; Yang, LJ | 1 |
| Cheng, X; Ding, XY; Ji, JD; Lu, TL; Mao, CQ; Su, LL; Wang, LJ; Zhang, J | 1 |
| Chang, YN; Guo, PP; Hao, HY; Hao, YM; Liu, QJ; Zhang, RJ; Zhi, ZJ; Zuo, HY | 1 |
| Cho, HY; Ham, SH; Jang, JH; Jeong, SH; Lee, YB; Yang, SJ | 1 |
| Feng, J; Li, T; Tan, Y; Tang, T; Xia, M; Yang, S; Zhao, H | 1 |
| Atsumi, T; Makino, T; Ohtsuka, I; Yokogawa, T; Yokoyama, Y | 1 |
| Freysdottir, J; Hanski, L; Karhu, E; Kortesoja, M; Olafsdottir, ES | 1 |
| Li, PB; Liang, FY; Ouyang, XS; Pei, Z; Su, WW; Wang, JW | 1 |
| Cao, JQ; Deng, ZW; Du, SS; Geng, ZF; Guo, SS; Liang, JY; Pang, X; Wang, Y | 1 |
| Arken, N | 1 |
| Bai, D; Cong, S; Yuan, X; Zhang, X; Zhao, Y | 1 |
| Chen, W; Ding, Z; Guo, Y; Hu, J; Jiang, Y; Xiao, J; Zhang, B; Zhang, Y | 1 |
| Fu, X; Li, J; Yu, Z; Zhu, P | 1 |
| Bi, K; Gao, H; Li, Q; Liu, H; Liu, R; Lv, X; Xu, H; Zhang, M; Zhang, Q; Zhang, Y | 1 |
| Bi, K; Cheng, X; Jia, Y; Jing, H; Qi, Y; Wu, B; Xiao, F; Yan, T | 1 |
| Kou, J; Li, F; Wang, G; Wang, T; Yu, B; Zhang, Y | 1 |
| Bruun, T; Hanski, L; Johansson, NG; Kortesoja, M; Taavitsainen, E | 1 |
| An, Q; Chen, S; Fu, BD; Huang, JN; Li, JH; Peng, LY; Shen, HQ; Song, K; Wu, SC; Yi, PF; Yu, JL; Yuan, M | 1 |
| Kou, JP; Lai, Q; Li, F; Liu, ZL; Wang, H; Yu, BY; Yuan, GY | 1 |
| Bi, K; Cheng, X; Du, Y; Gong, G; Jia, Y; Qi, Y; Wu, B; Yan, T | 1 |
| Lu, Y; Piao, Z; Song, L; Yao, L; Zhang, L | 2 |
| Dong, X; Du, X; Hao, X; Lin, L; Ni, J; Qu, C; Wu, H; Xie, L; Yin, X; Zhang, L | 1 |
| Ahn, SJ; In, S; Kim, E; Kim, HJ; Lee, A; Min, SS | 1 |
| Lee, KG; Park, M | 1 |
| Kou, J; Lai, Q; Li, F; Yang, W; Yu, B; Zhang, L; Zhang, Y | 1 |
| Bi, K; Gong, G; Jia, Y; Li, Y; Sun, Y; Wu, B; Yan, T; Zhang, J | 1 |
| Gao, H; Wang, X; Xu, Y; Zhang, S | 1 |
| Acharekar, N; Alagaratnam, A; Kong, J; Yoganathan, S | 1 |
| Kaifuchi, N; Matsumoto, T; Sakamoto, T; Setou, M; Takahashi, Y; Takiyama, M; Watanabe, J | 1 |
| Aras, A; Attar, R; Butt, G; Farooqi, AA; Lin, X; Mobeen, I; Yulaevna, IM | 1 |
| Cui, L; Huang, Q; Li, W; Liu, Y; Niu, X; Song, H; Yang, Y; Yu, J | 1 |
| Bu, F; He, Q; Li, M; Lin, HS; Lin, J; Mak, WY; Tang, Z; Wang, Q; Xiang, X; Zhu, X; Zhuang, X | 1 |
| Bi, K; Li, Q; Li, S; Xu, H; Yang, P; Zhang, Q; Zhang, Y | 1 |
| Han, M; Hu, JN; Jiang, S; Li, HP; Li, W; Ren, S; Tang, S; Wang, YM; Wang, Z; Zhang, H | 1 |
| Jung, UJ; Kim, SR; Park, HJ | 1 |
| Kotlík, J; Maršálek, B; Maršálková, E; Opatřilová, R; Valíčková, J; Zezulka, Š | 1 |
| Olas, B | 1 |
| Cuc, NT; Cuong, NT; Dung, DT; Hoang, NH; Kiem, PV; Nhiem, NX; Tai, BH; Thanh Huong, PT; Thanh, BV; Yen, PH | 1 |
| Choi, J; Hien, NTT; Hien, TTT; Kim, J; Kim, SH; Nhiem, NX; Tai, BH; Tai, PT; Thang, HD; Tram, LH; Tuan, HA; Tung, NM; Van Khoi, N; Van Kiem, P | 1 |
| Ekiert, H; Jafernik, K; Szopa, A | 1 |
| Jing, H; Li, H; Qiu, X; Song, H; Wang, C; Xu, M; Zhao, C; Zhuang, W | 1 |
| Hu, H; Li, Y; Wang, Z; Xu, C; Yang, K; You, Y; Zhao, L; Zhou, W | 1 |
| Fan, S; Ge, Y; Han, X; Lu, W; Shu, N; Tian, T; Xu, P; Yan, Y; Yang, Y | 1 |
8 review(s) available for schizandrin and lignans
| Article | Year |
|---|---|
Bioactivity of neolignans from fructus Schizandrae.
Topics: Alanine Transaminase; Animals; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Humans; Lignans; Lignin; Liver; Polycyclic Compounds | 1991 |
[Biochemical and pharmacologic effects of wuweizi (Schizandra chinensis (Turcz.) Baill.) and its chemical contents on animal livers].
Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cyclooctanes; Cytochrome P-450 Enzyme System; Drugs, Chinese Herbal; Lignans; Liver; Mitochondria, Liver; Polycyclic Compounds | 1988 |
[Phytotherapeutic aspects of diseases of the circulatory system. 7. Schisandra chinensis (Turcz.) Baill.): its composition and biological activity].
Topics: Cardiovascular Diseases; Cyclooctanes; Humans; Lignans; Plant Extracts; Plants, Medicinal; Polycyclic Compounds | 2001 |
Schisandra fruits for the management of drug-induced liver injury in China: A review.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Antioxidants; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; China; Cyclooctanes; Drugs, Chinese Herbal; Fruit; Humans; Lignans; Liver; Liver Regeneration; Phytotherapy; Polycyclic Compounds; Schisandra | 2019 |
Ellagic Acid and Schisandrins: Natural Biaryl Polyphenols with Therapeutic Potential to Overcome Multidrug Resistance in Cancer.
Topics: Animals; Cyclooctanes; Drug Discovery; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Ellagic Acid; Humans; Lignans; Neoplasms; Polycyclic Compounds; Polyphenols | 2021 |
Regulation of cell signaling pathways by Schisandrin in different cancers: Opting for "Swiss Army Knife" instead of "Blunderbuss".
Topics: Animals; Apoptosis; Carcinogenesis; Cell Movement; Clinical Trials as Topic; Cyclooctanes; Gene Expression Regulation, Neoplastic; Humans; Lignans; Neoplasms; Plant Extracts; Polycyclic Compounds; Protein Interaction Maps; Schisandra; Signal Transduction; Treatment Outcome | 2021 |
Cardioprotective Potential of Berries of
Topics: Anti-Inflammatory Agents; Antioxidants; Fruit; Lignans; Schisandra | 2023 |
Topics: China; Cyclooctanes; Lignans; Schisandra | 2023 |
173 other study(ies) available for schizandrin and lignans
| Article | Year |
|---|---|
The constituents of Schizandra chinensis Baill. I. Isolation and structure determination of five new lignans, gomisin A, B, C, F and G, and the absolute structure of schizandrin.
Topics: Chemical Phenomena; Chemistry; Cyclooctanes; Cycloparaffins; Dioxoles; Lignans; Molecular Conformation; Plant Extracts; Plants, Medicinal; Polycyclic Compounds | 1979 |
[Thin layer chromatographic studies on radix Ginseng, fructus Schisandrae and radix Salviae miltiorrhizae in yixinfumai granules].
Topics: Chromatography, Thin Layer; Cyclooctanes; Dioxoles; Drug Combinations; Drugs, Chinese Herbal; Ginsenosides; Lignans; Panax; Plants, Medicinal; Polycyclic Compounds; Saponins | 1992 |
[Metabolic transformation of schizandrin].
Topics: Animals; Biotransformation; Chromatography, High Pressure Liquid; Cyclooctanes; Lignans; Male; Microsomes, Liver; Polycyclic Compounds; Rats | 1992 |
[Effects of schizandrol A on monoamine neurotransmitters in the central nervous system].
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Brain; Corpus Striatum; Cyclooctanes; Dopamine; Hypothalamus; Lignans; Male; Neurotransmitter Agents; Polycyclic Compounds; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1991 |
[Antioxidation mechanism of schizandrin and tanshinonatic acid A and their effects on the protection of cardiotoxic action of adriamycin].
Topics: Animals; Cardiovascular Agents; Cyclooctanes; Doxorubicin; Drugs, Chinese Herbal; Free Radical Scavengers; Leukemia P388; Lignans; Malondialdehyde; Mitochondria, Heart; Phenanthrenes; Polycyclic Compounds | 1991 |
Scavenging effect of schizandrins on active oxygen radicals.
Topics: Cyclooctanes; Drugs, Chinese Herbal; Electron Spin Resonance Spectroscopy; Free Radicals; Humans; In Vitro Techniques; Lignans; Lymphocyte Activation; Molecular Structure; Neutrophils; Oximetry; Oxygen Consumption; Polycyclic Compounds; Tetradecanoylphorbol Acetate | 1990 |
Scavenging effects on active oxygen radicals by schizandrins with different structures and configurations.
Topics: Cyclooctanes; Drugs, Chinese Herbal; Electron Spin Resonance Spectroscopy; Free Radical Scavengers; Humans; Hydroxides; Hydroxyl Radical; Lignans; Neutrophils; Oxygen Consumption; Plants, Medicinal; Polycyclic Compounds; Superoxides | 1990 |
[Determination of the active ingredients in Chinese drug wuweizi (Schisandra chinensis) by TLC-densitometry].
Topics: Chromatography, Thin Layer; Cyclooctanes; Densitometry; Dioxoles; Drugs, Chinese Herbal; Lignans; Polycyclic Compounds | 1990 |
Pharmacological actions and clinical use of fructus schizandrae.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cyclooctanes; Cytochrome P-450 Enzyme System; Dioxoles; Drugs, Chinese Herbal; Hepatitis B; Humans; Lignans; Lipid Peroxidation; Mice; Microsomes, Liver; Polycyclic Compounds; Rats | 1989 |
[Preliminary studies on the processing of Schisandra chinensis].
Topics: Acetates; Biological Availability; Cyclooctanes; Hot Temperature; Lignans; Medicine, Chinese Traditional; Medicine, East Asian Traditional; Oils, Volatile; Plants, Medicinal; Polycyclic Compounds | 1986 |
[Induction of hepatic microsomal monooxygenases by schisanhenol in rats].
Topics: Animals; Cyclooctanes; Cytochrome P-450 Enzyme System; Enzyme Induction; Lignans; Male; Mice; Microsomes, Liver; Oxygenases; Polycyclic Compounds; Rats; Rats, Inbred Strains | 1985 |
[Experimental study on the enhancement of the immunosuppressive effect of cortisone by wurenchun, an extract of Schizandra chinensis Baill].
Topics: Animals; Antibody Formation; Cortisone; Cyclooctanes; Female; Immunosuppressive Agents; Lignans; Male; Medicine, Chinese Traditional; Medicine, East Asian Traditional; Mice; Plants, Medicinal; Polycyclic Compounds; Rosette Formation | 1985 |
[Pharmacological studies on an oil emulsion of Schisandra chinensis].
Topics: Animals; Cyclic AMP; Cyclooctanes; Emulsions; Lignans; Liver; Mice; Polycyclic Compounds | 1984 |
[Suppressive effect of wurenchun on the plaque forming cell (PFC) and specific rosette formation cell (SRFC) of mice].
Topics: Animals; Antibody-Producing Cells; Cyclooctanes; Dose-Response Relationship, Drug; Female; Immunosuppressive Agents; Lignans; Male; Mice; Polycyclic Compounds; Rosette Formation | 1984 |
[Metabolic fate of schizandrol A and its distribution in the rat brain determined by thin layer chromatography].
Topics: Animals; Brain; Chromatography, Thin Layer; Cyclooctanes; Kinetics; Lignans; Male; Mice; Polycyclic Compounds; Rats | 1983 |
[Effects of schizandrol on the central nervous system].
Topics: Aggression; Animals; Anticonvulsants; Brain; Catalepsy; Cyclooctanes; Humans; Lignans; Male; Mice; Motor Activity; Polycyclic Compounds; Rats; Sleep | 1983 |
Specific evidence that schizandrins induce a phenobarbital-like cytochrome P-450 form separated from rat liver.
Topics: Animals; Cyclooctanes; Cytochrome P-450 Enzyme System; Dioxolanes; Dioxoles; Hydrocarbons, Chlorinated; Immunodiffusion; Lignans; Male; Microsomes, Liver; Phenobarbital; Polycyclic Compounds; Rats; Rats, Inbred Strains | 1981 |
Pharmacological properties of dibenzo[a,c]cyclooctene derivatives isolated from Fructus Schizandrae chinensis. I. Interaction with rat liver cytochrome P-450 and inhibition of xenobiotic metabolism and mutagenicity.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Cyclooctanes; Cytochrome P-450 Enzyme System; Dioxoles; In Vitro Techniques; Lignans; Male; Medicine, Chinese Traditional; Medicine, East Asian Traditional; Microsomes, Liver; Mutagens; NADP; Oxidation-Reduction; Plants, Medicinal; Polycyclic Compounds; Rats; Rats, Inbred Strains | 1982 |
Pharmacological properties of Dibenzo[a,c]cyclooctene derivatives isolated from Fructus Schizandrae Chinensis III. Inhibitory effects on carbon tetrachloride-induced lipid peroxidation, metabolism and covalent binding of carbon tetrachloride to lipids.
Topics: Animals; Carbon Tetrachloride; China; Cyclooctanes; Dioxoles; Lignans; Lipid Metabolism; Lipid Peroxides; Male; Mice; Mice, Inbred DBA; Microsomes, Liver; NADP; Oxygen Consumption; Plants, Medicinal; Polycyclic Compounds | 1982 |
[Pharmacological studies on schizandra fruits. II. Effects of constituents of shizandra fruits on drugs induced hepatic damage in rats].
Topics: Animals; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Cyclooctanes; Cycloparaffins; Drug Evaluation, Preclinical; Lignans; Liver Diseases; Male; Plant Extracts; Plants, Medicinal; Polycyclic Compounds; Rats; Rats, Inbred Strains | 1982 |
[Synthesis of some derivatives of schizandrins (author's transl)].
Topics: Alanine Transaminase; Animals; Cyclooctanes; Hepatitis, Viral, Human; Lignans; Mice; Polycyclic Compounds; Structure-Activity Relationship | 1981 |
[Pharmacological studies on Schizandra fruit. I. General pharmacological effects of gomisin A and schizandrin (author's transl)].
Topics: Animals; Cyclooctanes; Cycloparaffins; Dioxoles; Drug Synergism; Guinea Pigs; Hexobarbital; Lignans; Male; Methamphetamine; Mice; Motor Activity; Plant Extracts; Plants, Medicinal; Polycyclic Compounds; Rats; Rats, Inbred Strains; Sleep | 1981 |
Structure determination of biliary metabolites of schizandrin in rat and dog.
Topics: Animals; Bile; Cyclooctanes; Dogs; Lignans; Magnetic Resonance Spectroscopy; Male; Molecular Structure; Plants, Medicinal; Polycyclic Compounds; Rats | 1995 |
Determination of schizandrin in human plasma by gas chromatography-mass spectrometry.
Topics: Cyclooctanes; Drug Stability; Gas Chromatography-Mass Spectrometry; Humans; Lignans; Male; Plants, Medicinal; Polycyclic Compounds; Sensitivity and Specificity | 1995 |
Structure-activity relationships of lignans from Schisandra chinensis as platelet activating factor antagonists.
Topics: Biphenyl Compounds; Cyclooctanes; Esterification; Hydroxylation; Lignans; Plants, Medicinal; Platelet Activating Factor; Polycyclic Compounds; Structure-Activity Relationship | 1999 |
Structure-activity relationship of schisandrins in enhancing liver mitochondrial glutathione status in CCl4-poisoned mice.
Topics: Animals; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Female; Glutathione; Glutathione Reductase; Lignans; Mice; Mice, Inbred BALB C; Mitochondria, Liver; Polycyclic Compounds; Structure-Activity Relationship | 1998 |
Effect of plant matrix and fluid ethanol concentration on supercritical fluid extraction efficiency of schisandrin derivatives.
Topics: Carbon Dioxide; Chromatography, High Pressure Liquid; Cyclooctanes; Ethanol; Fruit; Indicators and Reagents; Lignans; Plant Extracts; Plant Leaves; Plant Stems; Plants, Medicinal; Polycyclic Compounds; Solvents | 1999 |
Evaluation of the protective effects of Schisandra chinensis on Phase I drug metabolism using a CCl4 intoxication model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Area Under Curve; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cyclooctanes; Fruit; Hong Kong; Lignans; Liver; Liver Diseases; Male; Medicine, Chinese Traditional; Molecular Probes; Oxidation-Reduction; Plant Extracts; Plants, Medicinal; Polycyclic Compounds; Rats; Rats, Sprague-Dawley; Seeds | 1999 |
Rapid microbore liquid chromatographic analysis of biphenyldimethyl dicarboxylate in human plasma with on-line column switching.
Topics: Chromatography, Liquid; Cyclooctanes; Dioxoles; Hepatitis, Chronic; Humans; Lignans; Male; Plants, Medicinal; Polycyclic Compounds | 2000 |
Synthesis of the spirocyclic cyclohexadienone ring system of the schiarisanrins.
Topics: Cyclooctanes; Lignans; Plants, Medicinal; Polycyclic Compounds; Spiro Compounds | 2000 |
[Comparison of 4 extraction methods of chemical constituents in medicinal tea sishen chaji].
Topics: Cyclooctanes; Drug Combinations; Drugs, Chinese Herbal; Ficusin; Lignans; Plant Extracts; Polycyclic Compounds; Quinazolines; Technology, Pharmaceutical | 1997 |
The ameliorating effect of the water layer of Fructus Schisandrae on cycloheximide-induced amnesia in rats: interaction with drugs acting at neurotransmitter receptors.
Topics: Administration, Oral; Amnesia; Animals; Bicuculline; Cycloheximide; Cyclooctanes; Drugs, Chinese Herbal; Lignans; Male; p-Chloroamphetamine; Phytotherapy; Plants, Medicinal; Polycyclic Compounds; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Neurotransmitter; Ritanserin; Scopolamine; Water | 2001 |
[Phytotherapeutic aspects of diseases of the circulatory system. 8. Chinese magnolia (Schisandra chinensis (Turcz.) Baill.): production of the drugs and their evaluation, therapeutic and dietary preparations].
Topics: Cardiovascular Diseases; Cyclooctanes; Humans; Lignans; Plant Extracts; Plants, Medicinal; Polycyclic Compounds | 2001 |
[Total synthesis of schizandrin, the main active ingredient isolated from the Chinese herbal medicine fructus schizandrae].
Topics: Cyclooctanes; Lignans; Molecular Structure; Polycyclic Compounds; Schisandra | 1998 |
[A new bibenzyl derivative from Bletilla striata].
Topics: Bibenzyls; Cyclooctanes; Lignans; Molecular Structure; Orchidaceae; Plant Roots; Plants, Medicinal; Polycyclic Compounds | 2002 |
Total synthesis of (+)-isoschizandrin utilizing a samarium(II) iodide-promoted 8-endo ketyl-olefin cyclization.
Topics: Alkenes; Aza Compounds; Boron Compounds; Cyclization; Cyclooctanes; Iodides; Ketones; Lactones; Lignans; Models, Chemical; Molecular Structure; Polycyclic Compounds; Samarium; Schisandra; Stereoisomerism | 2003 |
Dibenzocyclooctadiene lignans from Schisandra chinensis protect primary cultures of rat cortical cells from glutamate-induced toxicity.
Topics: Animals; Calcium; Cells, Cultured; Cerebral Cortex; Cyclooctanes; Dioxoles; Dose-Response Relationship, Drug; Glutamic Acid; Intracellular Fluid; Lignans; Neurons; Neuroprotective Agents; Neurotoxins; Peroxides; Phytotherapy; Plant Extracts; Polycyclic Compounds; Rats; Schisandra | 2004 |
[Studies on extraction process of Fructus Schisandrae chinensis and Fructus Ligustri lucidi in gandening tablet].
Topics: Alcohols; Chemistry, Pharmaceutical; Chromatography, Supercritical Fluid; Cyclooctanes; Drug Combinations; Drugs, Chinese Herbal; Fruit; Lignans; Ligustrum; Plants, Medicinal; Polycyclic Compounds; Schisandra; Technology, Pharmaceutical | 2004 |
[Study on the simultaneous spectrophotometric determination of three components including deoxyschizandrin by ridge regression method].
Topics: Cyclooctanes; Lignans; Polycyclic Compounds; Regression Analysis; Spectrophotometry | 2004 |
Application of preparative high-speed counter-current chromatography for isolation and separation of schizandrin and gomisin A from Schisandra chinensis.
Topics: Chromatography, High Pressure Liquid; Countercurrent Distribution; Cyclooctanes; Dioxoles; Lignans; Polycyclic Compounds; Schisandra | 2005 |
Determination of schizandrin in rat plasma by high-performance liquid chromatography-mass spectrometry and its application in rat pharmacokinetic studies.
Topics: Animals; Chromatography, High Pressure Liquid; Cyclooctanes; Drug Stability; Lignans; Mass Spectrometry; Polycyclic Compounds; Rats; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2005 |
[Deterimination of schisandrin in Kadsura heteroclita (Roxb.) Craib by RP-HPLC].
Topics: Chromatography, High Pressure Liquid; Cyclooctanes; Kadsura; Lignans; Plant Stems; Plants, Medicinal; Polycyclic Compounds; Quality Control; Reproducibility of Results | 2006 |
[Relationship between components changes and efficacy of Shengmaisan VII. Chemical dynamic change of schisandrin in Shengmaisan].
Topics: Cyclooctanes; Drug Combinations; Drug Interactions; Drugs, Chinese Herbal; Ginsenosides; Lignans; Ophiopogon; Panax; Plants, Medicinal; Polycyclic Compounds; Schisandra | 2006 |
Amyloid-beta-induced cytotoxicity of PC-12 cell was attenuated by Shengmai-san through redox regulation and outgrowth induction.
Topics: alpha-Tocopherol; Amyloid beta-Peptides; Animals; Apoptosis; bcl-Associated Death Protein; Caspase 3; Caspase Inhibitors; Cell Survival; Chromatography, High Pressure Liquid; Cyclooctanes; Dioxoles; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Combinations; Drugs, Chinese Herbal; Flow Cytometry; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Heme Oxygenase-1; Lignans; MAP Kinase Kinase 4; Oxidation-Reduction; PC12 Cells; Polycyclic Compounds; Rats; Time Factors | 2007 |
Inhibitory effect of schizandrin on passive cutaneous anaphylaxis reaction and scratching behaviors in mice.
Topics: Animals; Anti-Allergic Agents; Cyclooctanes; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Interleukin-4; Lignans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Molecular Structure; p-Methoxy-N-methylphenethylamine; Passive Cutaneous Anaphylaxis; Plant Extracts; Polycyclic Compounds; Pruritus; Schisandra; Tumor Necrosis Factor-alpha | 2007 |
Schizandrin reverses memory impairment in rats.
Topics: Animals; Avoidance Learning; Cyclooctanes; Dose-Response Relationship, Drug; Lignans; Male; Maze Learning; Memory Disorders; Molecular Structure; Muscarinic Antagonists; Oxotremorine; Phytotherapy; Polycyclic Compounds; Rats; Rats, Wistar; Schisandra; Scopolamine | 2008 |
[Enzyme kinetics of schizandrin metabolism and sex differences in rat liver microsomes].
Topics: Animals; Chromatography, High Pressure Liquid; Cimetidine; Cyclooctanes; Enzyme Inhibitors; Female; In Vitro Techniques; Ketoconazole; Lignans; Male; Microsomes, Liver; Orphenadrine; Plants, Medicinal; Polycyclic Compounds; Rats; Rats, Sprague-Dawley; Schisandra; Sex Factors; Spectrophotometry, Ultraviolet | 2007 |
Molecular mechanism of apoptosis induced by schizandrae-derived lignans in human leukemia HL-60 cells.
Topics: Apoptosis; Caspase 3; Cell Survival; Cyclooctanes; DNA Fragmentation; HL-60 Cells; Humans; Lignans; Molecular Biology; Phytotherapy; Plant Preparations; Polycyclic Compounds; Schisandra; Structure-Activity Relationship | 2008 |
Pharmacokinetic comparisons of schizandrin after oral administration of schizandrin monomer, Fructus Schisandrae aqueous extract and Sheng-Mai-San to rats.
Topics: Administration, Oral; Animals; Area Under Curve; Biological Availability; Chromatography, Liquid; Cyclooctanes; Drugs, Chinese Herbal; Female; Fruit; Half-Life; Lignans; Mass Spectrometry; Medicine, Chinese Traditional; Ophiopogon; Panax; Polycyclic Compounds; Random Allocation; Rats; Rats, Sprague-Dawley; Schisandra; Solubility; Time Factors | 2008 |
Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae.
Topics: Animals; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cyclooctanes; Dioxoles; Doxorubicin; Drug Evaluation, Preclinical; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drugs, Chinese Herbal; Fruit; Genes, MDR; Humans; Lignans; Mice; Mice, Nude; Neoplasm Proteins; Phytotherapy; Plant Preparations; Polycyclic Compounds; Protein Kinase C; Schisandra; Xenograft Model Antitumor Assays | 2008 |
Neglschisandrins A-B: two new dibenzocyclooctene lignans from Schisandra neglecta.
Topics: Cyclooctanes; Lignans; Magnetic Resonance Spectroscopy; Polycyclic Compounds; Schisandra | 2008 |
Schizandrin protects primary cultures of rat cortical cells from glutamate-induced excitotoxicity.
Topics: Animals; Apoptosis; Calcium; Caspases; Cells, Cultured; Cerebral Cortex; Cyclooctanes; Cytochromes c; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Glutamic Acid; Glutathione; Lignans; Lipid Peroxidation; Membrane Potential, Mitochondrial; Mitochondria; Neurons; Neuroprotective Agents; Nitric Oxide; Oxidative Stress; Poly(ADP-ribose) Polymerases; Polycyclic Compounds; Rats; Reactive Oxygen Species | 2008 |
Neglschisandrins C-D: two new dibenzocyclooctadiene lignans from Schisandra neglecta.
Topics: Cyclooctanes; Lignans; Magnetic Resonance Spectroscopy; Polycyclic Compounds; Schisandra | 2008 |
Anti-inflammatory effects of schisandrin isolated from the fruit of Schisandra chinensis Baill.
Topics: Animals; Anti-Inflammatory Agents; Capillary Permeability; Cell Line; Cyclooctanes; Cyclooxygenase 2; Dinoprostone; Fruit; Gene Expression Regulation; Inflammation; Lignans; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred ICR; Nitric Oxide; Nitric Oxide Synthase Type II; Nitrites; Polycyclic Compounds; Schisandra; Sepsis | 2008 |
Nordihydroguaiaretic acid autoxidation produces a schisandrin-like dibenzocyclooctadiene lignan.
Topics: Cyclooctanes; Lignans; Masoprocol; Molecular Structure; Oxidation-Reduction; Polycyclic Compounds; Stereoisomerism | 2008 |
Optimization of extraction and purification of active fractions from Schisandra chinensis (Turcz.) and its osteoblastic proliferation stimulating activity.
Topics: Alkaline Phosphatase; Animals; Cell Line; Cell Proliferation; Chromatography, High Pressure Liquid; Cyclooctanes; Enzyme Activators; Lignans; Osteoblasts; Plant Extracts; Polycyclic Compounds; Rats; Schisandra | 2009 |
[Lignans from different processed products of Schisandra chinensis fruits].
Topics: Chromatography, High Pressure Liquid; Cyclooctanes; Dioxoles; Drug Compounding; Drugs, Chinese Herbal; Fruit; Hot Temperature; Lignans; Plants, Medicinal; Polycyclic Compounds; Quality Control; Schisandra; Spectrometry, Mass, Electrospray Ionization | 2008 |
Nortriterpenoids and lignans from Schisandra sphenanthera.
Topics: Cell Line; Cyclooctanes; Dioxoles; HeLa Cells; HIV-1; Humans; Lignans; Microbial Sensitivity Tests; Plant Extracts; Polycyclic Compounds; Schisandra; Triterpenes | 2008 |
[Effects of schisandra on the function of the pituitary-adrenal cortex, gonadal axis and carbohydrate metabolism in rats undergoing experimental chronic psychological stress, navigation and strenuous exercise].
Topics: Animals; Blood Glucose; Carbohydrate Metabolism; Corticosterone; Cyclooctanes; Hyperkinesis; Lignans; Male; Physical Conditioning, Animal; Phytotherapy; Pituitary-Adrenal System; Polycyclic Compounds; Rats; Rats, Sprague-Dawley; Schisandra; Stress, Psychological | 2009 |
Inhibitory effects of Schizandrae Fructus on eotaxin secretion in A549 human epithelial cells and eosinophil migration.
Topics: Cell Line; Cell Migration Inhibition; Chemokines, CC; Chemotaxis, Leukocyte; Cyclooctanes; Cytokines; Eosinophilia; Eosinophils; Epithelial Cells; Fruit; Humans; Intercellular Adhesion Molecule-1; Lignans; Lung; Plant Extracts; Polycyclic Compounds; Respiratory Mucosa; RNA, Messenger; Schisandra; Vascular Cell Adhesion Molecule-1 | 2009 |
Effects of schisandrin on transcriptional factors in lipopolysaccharide-pretreated macrophages.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cyclooctanes; Cyclooxygenase 2; Dose-Response Relationship, Drug; I-kappa B Proteins; JNK Mitogen-Activated Protein Kinases; Lignans; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Polycyclic Compounds; Time Factors; Transcription Factors | 2009 |
Growth inhibition and cell cycle arrest in the G0/G1 by schizandrin, a dibenzocyclooctadiene lignan isolated from Schisandra chinensis, on T47D human breast cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor Proteins; Cyclooctanes; Female; Humans; Lignans; Molecular Structure; Polycyclic Compounds; Schisandra | 2010 |
[Selection of mobile phases for the determination of gamma-schisandrin and multi-active constituents in Schisandra chinensis and its preparations by high performance liquid chromatography].
Topics: Chromatography, High Pressure Liquid; Cyclooctanes; Drugs, Chinese Herbal; Lignans; Polycyclic Compounds; Schisandra | 2009 |
Highly sensitive determination of Schisandrin and Schisandrin B in plasma of rats after administration of Wurenchun (Fructus Schisandrae Chinensis Extracts) preparations by LC-ESI-MS/MS.
Topics: Animals; Chromatography, Liquid; Cyclooctanes; Drugs, Chinese Herbal; Lignans; Male; Polycyclic Compounds; Rats; Rats, Sprague-Dawley; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2010 |
CYP3A catalyses schizandrin biotransformation in human, minipig and rat liver microsomes.
Topics: Animals; Catalysis; Chromatography, High Pressure Liquid; Cyclooctanes; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Humans; Ketoconazole; Lignans; Mass Spectrometry; Metabolic Networks and Pathways; Microsomes, Liver; Polycyclic Compounds; Rats; Swine; Swine, Miniature; Troleandomycin | 2010 |
[Preparation of enteric nanoparticles of Schisandra total lignanoids and preliminary study on its pharmacokinetics].
Topics: Animals; Area Under Curve; Biological Availability; Cyclooctanes; Female; Lignans; Male; Nanoparticles; Particle Size; Polycyclic Compounds; Rats; Rats, Sprague-Dawley; Schisandra | 2009 |
A simple and sensitive HPLC method for the simultaneous determination of eight bioactive components and fingerprint analysis of Schisandra sphenanthera.
Topics: Chromatography, High Pressure Liquid; Cyclooctanes; Dioxoles; Fruit; Lignans; Mass Spectrometry; Plant Extracts; Polycyclic Compounds; Reproducibility of Results; Schisandra | 2010 |
Derivatives of schisandrin with increased inhibitory potential on prostaglandin E(2) and leukotriene B(4) formation in vitro.
Topics: Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Circular Dichroism; Cyclooctanes; Cyclooxygenase 1; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Indicators and Reagents; Leukotriene B4; Lignans; Lipoxygenase Inhibitors; Magnetic Resonance Spectroscopy; Polycyclic Compounds; Schisandra; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship | 2010 |
[Changes of lignans' content in stems of Schisandra chinensis].
Topics: Chromatography, High Pressure Liquid; Cyclooctanes; Lignans; Plant Stems; Polycyclic Compounds; Schisandra | 2009 |
Anti-asthmatic effect of schizandrin on OVA-induced airway inflammation in a murine asthma model.
Topics: Animals; Anti-Asthmatic Agents; Asthma; Bronchoalveolar Lavage Fluid; Cyclooctanes; Cytokines; Disease Models, Animal; Eosinophils; Female; Goblet Cells; Hyperplasia; Immunoglobulin E; Lignans; Lung; Mice; Mice, Inbred BALB C; Oxidative Stress; Polycyclic Compounds; Reactive Oxygen Species; Th1 Cells; Th2 Cells | 2010 |
Protective effects of dibenzocyclooctadiene lignans from Schisandra chinensis against beta-amyloid and homocysteine neurotoxicity in PC12 cells.
Topics: Amyloid beta-Peptides; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cyclooctanes; Dioxoles; Homocysteine; Lignans; Neuroprotective Agents; PC12 Cells; Peptide Fragments; Polycyclic Compounds; Rats; Reactive Oxygen Species; Schisandra | 2011 |
Enhanced oral bioavailability of Wurenchun (Fructus Schisandrae Chinensis extracts) by self-emulsifying drug delivery systems.
Topics: Administration, Oral; Animals; Area Under Curve; Biological Availability; Cyclooctanes; Drug Delivery Systems; Drugs, Chinese Herbal; Emulsions; Excipients; Fruit; Lignans; Male; Particle Size; Plant Extracts; Polycyclic Compounds; Rats; Rats, Sprague-Dawley; Schisandra; Solubility | 2010 |
[The effect of the stimulator-schizandra on neuro-muscular excitability in man].
Topics: Cyclooctanes; Humans; Lignans; Muscles; Polycyclic Compounds; Schisandra | 1945 |
Schisandrin enhances dendrite outgrowth and synaptogenesis in primary cultured hippocampal neurons.
Topics: Animals; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cyclic AMP Response Element-Binding Protein; Cyclic Nucleotide Phosphodiesterases, Type 1; Cyclooctanes; Dendrites; Fruit; Hippocampus; Lignans; Mitogen-Activated Protein Kinase Kinases; Neurogenesis; Phosphorylation; Plant Extracts; Polycyclic Compounds; Post-Synaptic Density; Presynaptic Terminals; Protein Kinase C-epsilon; Rats; Rats, Wistar; Schisandra | 2011 |
Schiglautone A, a new tricyclic triterpenoid with a unique 6/7/9-fused skeleton from the stems of Schisandra glaucescens.
Topics: Crystallography, X-Ray; Cyclooctanes; Lignans; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Plant Stems; Polycyclic Compounds; Schisandra; Triterpenes | 2011 |
Study on ionic liquid-based ultrasonic-assisted extraction of biphenyl cyclooctene lignans from the fruit of Schisandra chinensis Baill.
Topics: Chromatography, High Pressure Liquid; Cyclooctanes; Fruit; Ionic Liquids; Lignans; Plant Extracts; Polycyclic Compounds; Schisandra; Solid Phase Extraction; Time Factors; Ultrasonics | 2011 |
Inhibitory effect of schisandrin on spontaneous contraction of isolated rat colon.
Topics: Adrenergic Antagonists; Animals; Atropine; Benzyl Compounds; Colon, Ascending; Cyclic GMP; Cyclooctanes; Enzyme Inhibitors; Imidazoles; In Vitro Techniques; Lignans; Male; Muscle Contraction; Muscle Relaxation; Nitric Oxide; Phentolamine; Plant Extracts; Polycyclic Compounds; Propranolol; Purinergic Antagonists; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley; Receptors, Epoprostenol; Schisandra; Tetrodotoxin; Xanthines | 2011 |
Simultaneous and rapid determination of main lignans in different parts of Schisandra sphenanthera by micellar electrokinetic capillary chromatography.
Topics: Chromatography, Micellar Electrokinetic Capillary; Cyclooctanes; Dioxoles; Lignans; Polycyclic Compounds | 2011 |
Upregulation of heme oxygenase-1 via PI3K/Akt and Nrf-2 signaling pathways mediates the anti-inflammatory activity of Schisandrin in Porphyromonas gingivalis LPS-stimulated macrophages.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cell Nucleus; Cyclooctanes; Enzyme Activation; Gene Expression Regulation; Heme Oxygenase-1; Inflammation; Inflammation Mediators; Lignans; Lipopolysaccharides; Macrophages; Mice; NF-E2-Related Factor 2; NF-kappa B; Phosphatidylinositol 3-Kinases; Polycyclic Compounds; Porphyromonas gingivalis; Protein Transport; Proto-Oncogene Proteins c-akt; Signal Transduction; Up-Regulation | 2011 |
Relaxant effects of Schisandra chinensis and its major lignans on agonists-induced contraction in guinea pig ileum.
Topics: Acetylcholine; Animals; Calcium; Chromatography, High Pressure Liquid; Cyclooctanes; Drugs, Chinese Herbal; Guinea Pigs; Ileum; In Vitro Techniques; Lignans; Male; Muscle Contraction; Muscle Relaxants, Central; Parasympatholytics; Plant Extracts; Plants, Medicinal; Polycyclic Compounds; Receptor, Muscarinic M3; Schisandra; Serotonin | 2011 |
Preparation of high purity biphenyl cyclooctene lignans from Schisandra extract by ion exchange resin catalytic transformation combined with macroporous resin separation.
Topics: Adsorption; Analysis of Variance; Chromatography, Ion Exchange; Cyclooctanes; Dioxoles; Ethanol; Fruit; Hydrolysis; Ion Exchange Resins; Lignans; Plant Extracts; Polycyclic Compounds; Schisandra; Spectrometry, Mass, Electrospray Ionization; Temperature | 2011 |
Schizandrin prevents damage of murine mesangial cells via blocking NADPH oxidase-induced ROS signaling in high glucose.
Topics: Animals; Cell Line, Transformed; Cell Proliferation; Collagen Type IV; Cyclooctanes; Fibronectins; Glomerular Mesangium; Glucose; Lignans; MAP Kinase Signaling System; Mice; NADPH Oxidases; Phosphorylation; Polycyclic Compounds; Reactive Oxygen Species; Signal Transduction; Transforming Growth Factor beta1 | 2012 |
[Effects of schizandrins on learning-memory disorder in mice].
Topics: Animals; Apoptosis; Behavior, Animal; CA1 Region, Hippocampal; Caspase 3; Cell Line; Cyclooctanes; Disease Models, Animal; Drugs, Chinese Herbal; Female; Learning Disabilities; Lignans; Male; Memory Disorders; Mice; Nitric Oxide; Oxidative Stress; PC12 Cells; Polycyclic Compounds; Proto-Oncogene Proteins c-bcl-2; Rats; Superoxide Dismutase; Transcription Factor RelA | 2011 |
[Pharmacokinetics interaction among three major active compounds of Shengmai formula in rats].
Topics: Animals; Biological Availability; Chromatography, Liquid; Cyclooctanes; Drug Synergism; Ginsenosides; Lignans; Male; Polycyclic Compounds; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry | 2012 |
[Pharmacokinetics and tissue distribution of Schisandra chinensis extract in mice].
Topics: Administration, Oral; Animals; Area Under Curve; Chromatography, High Pressure Liquid; Cyclooctanes; Fruit; Kidney; Lignans; Liver; Lung; Male; Mice; Plant Extracts; Polycyclic Compounds; Schisandra; Spleen; Tissue Distribution | 2011 |
[Study on the chemical constituents of vinegar Schisandra chinensis].
Topics: Acetic Acid; Cyclooctanes; Fruit; Lignans; Magnetic Resonance Spectroscopy; Molecular Structure; Plants, Medicinal; Polycyclic Compounds; Schisandra; Sitosterols; Technology, Pharmaceutical | 2011 |
Schizandrin, an antioxidant lignan from Schisandra chinensis, ameliorates Aβ1-42-induced memory impairment in mice.
Topics: Amyloid beta-Peptides; Animals; Antioxidants; Biological Assay; Cerebral Cortex; Cyclooctanes; Hippocampus; Lignans; Male; Maze Learning; Memory Disorders; Mice; Motor Activity; Peptide Fragments; Polycyclic Compounds; Reaction Time; Schisandra | 2012 |
Effects of schizandrin on the expression of thymic stromal lymphopoietin in human mast cell line HMC-1.
Topics: Blotting, Western; Calcimycin; Caspase 1; Cell Line; Cyclooctanes; Cytokines; Enzyme-Linked Immunosorbent Assay; Humans; Lignans; Luciferases; Mast Cells; Polycyclic Compounds; Reverse Transcriptase Polymerase Chain Reaction; Tetradecanoylphorbol Acetate; Thymic Stromal Lymphopoietin | 2012 |
Schizandrin prevents dexamethasone-induced cognitive deficits.
Topics: Animals; Animals, Newborn; Cell Survival; Cells, Cultured; Cerebral Cortex; Cognition Disorders; Cyclooctanes; Dexamethasone; Dose-Response Relationship, Drug; Lignans; Male; Mice; Neuroprotective Agents; Polycyclic Compounds; Random Allocation; Rats; Rats, Sprague-Dawley; Schisandra | 2012 |
Dietary Fructus Schisandrae extracts and fenofibrate regulate the serum/hepatic lipid-profile in normal and hypercholesterolemic mice, with attention to hepatotoxicity.
Topics: Animals; Cyclooctanes; Diet; Drugs, Chinese Herbal; Fenofibrate; Fruit; Hypercholesterolemia; Hypolipidemic Agents; Lignans; Lipid Metabolism; Lipids; Liver; Mice; Polycyclic Compounds; Triglycerides | 2012 |
[Simultaneous quantitative analysis of four lignanoids in Schisandra chinensis by quantitative analysis of multi-components by single marker].
Topics: Chromatography, High Pressure Liquid; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Fruit; Lignans; Plants, Medicinal; Polycyclic Compounds; Quality Control; Schisandra | 2012 |
Schizandrin protects primary rat cortical cell cultures from glutamate-induced apoptosis by inhibiting activation of the MAPK family and the mitochondria dependent pathway.
Topics: Animals; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Blotting, Western; Caspase 12; Cells, Cultured; Cerebral Cortex; Cyclooctanes; Fas Ligand Protein; fas Receptor; Glutamic Acid; Lignans; Mitochondria; Mitogen-Activated Protein Kinases; Neuroprotective Agents; Phosphorylation; Polycyclic Compounds; Primary Cell Culture; Signal Transduction; Tumor Suppressor Protein p53 | 2012 |
Pharmacokinetic study of schisandrin, schisandrol B, schisantherin A, deoxyschisandrin, and schisandrin B in rat plasma after oral administration of Shengmaisan formula by UPLC-MS.
Topics: Administration, Oral; Animals; Chromatography, High Pressure Liquid; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Lignans; Male; Polycyclic Compounds; Rats; Rats, Wistar; Spectrometry, Mass, Electrospray Ionization | 2013 |
Development of a UFLC-MS/MS method for simultaneous determination of six lignans of Schisandra chinensis (Turcz.) Baill. in rat plasma and its application to a comparative pharmacokinetic study in normal and insomnic rats.
Topics: Animals; Chromatography, High Pressure Liquid; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Lignans; Male; Medicine, Chinese Traditional; Polycyclic Compounds; Random Allocation; Rats; Rats, Sprague-Dawley; Schisandra; Sensitivity and Specificity; Sleep Initiation and Maintenance Disorders; Tandem Mass Spectrometry | 2013 |
Neglschisandrins E-F: two new lignans and related cytotoxic lignans from Schisandra neglecta.
Topics: Cell Death; Cell Line, Tumor; Cyclooctanes; Drug Screening Assays, Antitumor; Humans; Lignans; Magnetic Resonance Spectroscopy; Models, Molecular; Polycyclic Compounds; Schisandra | 2013 |
Effect of acupuncture on target tissue distribution of Schisandra lignans.
Topics: Acupuncture Therapy; Animals; Chromatography, High Pressure Liquid; Cyclooctanes; Lignans; Polycyclic Compounds; Rats; Spectrometry, Mass, Electrospray Ionization; Substrate Specificity; Tandem Mass Spectrometry; Tissue Distribution | 2013 |
Ultra-performance liquid-chromatography with tandem mass spectrometry for rapid analysis of pharmacokinetics, biodistribution and excretion of schisandrin after oral administration of Shengmaisan.
Topics: Administration, Oral; Animals; Chromatography, High Pressure Liquid; Cyclooctanes; Drug Combinations; Drugs, Chinese Herbal; Feces; Lignans; Male; Organ Specificity; Polycyclic Compounds; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2013 |
Chemical-pharmacokinetic-pharmacodynamic fingerprints of Schisandra chinensis alcoholic extract.
Topics: Alanine Transaminase; Animals; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure Liquid; Cyclooctanes; Drugs, Chinese Herbal; Lignans; Male; Microsomes, Liver; Plants, Medicinal; Polycyclic Compounds; Random Allocation; Rats; Rats, Sprague-Dawley; Schisandra; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet | 2013 |
Protective effects of schizandrin and schizandrin B towards cisplatin nephrotoxicity in vitro.
Topics: Antineoplastic Agents; Cell Culture Techniques; Cell Cycle; Cell Line; Cell Survival; Cisplatin; Collagen; Cyclooctanes; Epithelial Cells; Fruit; Humans; Kidney Tubules, Proximal; Lignans; Molecular Structure; Polycyclic Compounds; Protective Agents; Schisandra | 2014 |
Effects of drugs on exercise performance.
Topics: Administration, Oral; Animals; Animals, Outbred Strains; Antioxidants; Central Nervous System Stimulants; Cyclooctanes; Imidazoles; Lignans; Organometallic Compounds; Oxidative Stress; Physical Conditioning, Animal; Physical Endurance; Polycyclic Compounds; Rats; Swimming | 2013 |
A pharmacokinetic and pharmacodynamic study of drug-drug interaction between ginsenoside Rg1, ginsenoside Rb1 and schizandrin after intravenous administration to rats.
Topics: Administration, Intravenous; Animals; Area Under Curve; Chromatography, High Pressure Liquid; Cyclooctanes; Drug Interactions; Drug Synergism; Ginsenosides; Half-Life; Lignans; Male; Medicine, Chinese Traditional; Models, Biological; Nitric Oxide; Panax; Polycyclic Compounds; Rats; Rats, Sprague-Dawley; Schisandra | 2014 |
Comparative pharmacokinetics and tissue distribution of schisandrin, deoxyschisandrin and schisandrin B in rats after combining acupuncture and herb medicine (schisandra chinensis).
Topics: Acupuncture Therapy; Administration, Oral; Animals; Chromatography, High Pressure Liquid; Cyclooctanes; Lignans; Linear Models; Plant Extracts; Polycyclic Compounds; Rats; Schisandra; Spectrometry, Mass, Electrospray Ionization; Tissue Distribution | 2014 |
Simultaneous determination of calycosin-7-O-β-d-glucoside, calycosin, formononetin, astragaloside IV and schisandrin in rat plasma by LC-MS/MS: application to a pharmacokinetic study after oral administration of Shenqi Wuwei chewable tablets.
Topics: Administration, Oral; Animals; Chromatography, High Pressure Liquid; Cyclooctanes; Drug Stability; Drugs, Chinese Herbal; Glucosides; Isoflavones; Lignans; Linear Models; Male; Polycyclic Compounds; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Saponins; Sensitivity and Specificity; Tablets; Tandem Mass Spectrometry; Triterpenes | 2014 |
[High performance preparation and structural confirmation of lignans from Schisandrae chinensis fructus by using HSCCC combined with ESI-MSn method].
Topics: Countercurrent Distribution; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Fruit; Lignans; Molecular Structure; Plants, Medicinal; Polycyclic Compounds; Schisandra; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2014 |
A combination of four active compounds alleviates cerebral ischemia-reperfusion injury in correlation with inhibition of autophagy and modulation of AMPK/mTOR and JNK pathways.
Topics: Adenine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Autophagy; Brain; Brain Infarction; Cyclooctanes; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drugs, Chinese Herbal; Ginsenosides; Infarction, Middle Cerebral Artery; Lignans; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Polycyclic Compounds; Renal Circulation; Reperfusion Injury; Saponins; Time Factors; TOR Serine-Threonine Kinases | 2014 |
Network pharmacology-based prediction and verification of the molecular targets and pathways for schisandrin against cerebrovascular disease.
Topics: Animals; Cerebrovascular Disorders; Cyclooctanes; Drugs, Chinese Herbal; Gene Regulatory Networks; Humans; Lignans; Molecular Targeted Therapy; PC12 Cells; Polycyclic Compounds; Protein Interaction Maps; Rats; Signal Transduction | 2014 |
[Determination of five components in rongxin pills by HPLC].
Topics: Abietanes; Chromatography, High Pressure Liquid; Cyclooctanes; Drugs, Chinese Herbal; Lignans; Linear Models; Organic Chemicals; Phenanthrenes; Polycyclic Compounds; Quality Control; Reproducibility of Results | 2014 |
A metabonomic study of cardioprotection of ginsenosides, schizandrin, and ophiopogonin D against acute myocardial infarction in rats.
Topics: Animals; Cyclooctanes; Drug Combinations; Drugs, Chinese Herbal; Ginsenosides; Lignans; Magnetic Resonance Spectroscopy; Male; Metabolome; Metabolomics; Myocardial Infarction; Polycyclic Compounds; Rats; Rats, Sprague-Dawley; Saponins; Spirostans | 2014 |
The beneficial effects of combined grape pomace and omija fruit extracts on hyperglycemia, adiposity and hepatic steatosis in db/db mice: a comparison with major index compounds.
Topics: Adiponectin; Adiposity; Animals; Biomarkers; Blood Glucose; Cyclooctanes; Diabetes Mellitus, Experimental; Fatty Liver; Fruit; Glycated Hemoglobin; Hyperglycemia; Insulin; Leptin; Lignans; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Plant Extracts; Polycyclic Compounds; Resistin; Resveratrol; Schisandra; Stilbenes; Vitis | 2014 |
Pharmacological evaluation of sedative and hypnotic effects of schizandrin through the modification of pentobarbital-induced sleep behaviors in mice.
Topics: 5-Hydroxytryptophan; Animals; Caffeine; Cyclooctanes; Fenclonine; Flumazenil; Fruit; GABA Antagonists; Hypnotics and Sedatives; Lignans; Locomotion; Male; Mice; Pentobarbital; Polycyclic Compounds; Sleep | 2014 |
[Network analysis of ethanol precipitation process for Schisandrae chinensis fructus].
Topics: Bayes Theorem; Chemical Precipitation; Cold Temperature; Cyclooctanes; Ethanol; Fructose; Fruit; Glucose; Lignans; Neural Networks, Computer; Polycyclic Compounds; Reproducibility of Results; Schisandra; Time Factors | 2014 |
Schizandrin ameliorates ovariectomy-induced memory impairment, potentiates neurotransmission and exhibits antioxidant properties.
Topics: Acetylcholinesterase; Animals; Antioxidants; Avoidance Learning; Cell Count; Cyclooctanes; Excitatory Postsynaptic Potentials; Female; GPI-Linked Proteins; Hippocampus; Lignans; Long-Term Potentiation; Malondialdehyde; Memory Disorders; Ovariectomy; Polycyclic Compounds; Rats; Superoxide Dismutase; Synaptic Transmission | 2015 |
Schizandrin inhibits fibrosis and epithelial-mesenchymal transition in transforming growth factor-β1-stimulated AML12 cells.
Topics: Animals; Cell Line; Cyclooctanes; Epithelial-Mesenchymal Transition; Fibrosis; Lignans; Liver Diseases; Mice; Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Polycyclic Compounds; RNA, Small Interfering; Smad2 Protein; Smad3 Protein; Smad4 Protein; Transforming Growth Factor beta1 | 2015 |
[Determination of lignanoids in seeds of Schisandra chinensis by combinative methods of fingerprint and QAMS].
Topics: Chromatography, High Pressure Liquid; Cyclooctanes; Dioxoles; Lignans; Polycyclic Compounds; Reproducibility of Results; Schisandra; Seeds | 2014 |
Inhibitory effects of emodin, baicalin, schizandrin and berberine on hefA gene: treatment of Helicobacter pylori-induced multidrug resistance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Berberine; Cyclooctanes; Drug Resistance, Multiple, Bacterial; Drugs, Chinese Herbal; Emodin; Flavonoids; Gene Expression Regulation, Bacterial; Helicobacter pylori; Lignans; Membrane Transport Proteins; Microbial Sensitivity Tests; Polycyclic Compounds; RNA, Messenger | 2015 |
[Study on chemical constituents from Schisandra chinensis stem].
Topics: Cyclooctanes; Guaiacol; Lignans; Phytochemicals; Plant Stems; Polycyclic Compounds; Schisandra; Sitosterols | 2014 |
[Chemical constituents from supercritical CO2 extraction of Schisandra chinensis].
Topics: Cyclooctanes; Lignans; Phytochemicals; Polycyclic Compounds; Schisandra; Sitosterols | 2014 |
Isolation of three dibenzocyclooctadiene lignans from in vitro cultures of Schisandra chinensis (Turcz.) Baill.--the first report.
Topics: Cells, Cultured; Chromatography, Thin Layer; Cyclooctanes; Dioxoles; Lignans; Magnetic Resonance Spectroscopy; Plant Leaves; Plant Shoots; Polycyclic Compounds; Schisandra | 2015 |
Inhibition of UDP-Glucuronosyltransferases (UGTs) Activity by constituents of Schisandra chinensis.
Topics: Animals; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Glucuronosyltransferase; Herb-Drug Interactions; Lignans; Plant Extracts; Polycyclic Compounds; Rats; Schisandra; Structure-Activity Relationship | 2015 |
Identification of schisandrin as a vascular endothelium protective component in YiQiFuMai Powder Injection using HUVECs binding and HPLC-DAD-Q-TOF-MS/MS analysis.
Topics: Apoptosis; Cardiovascular Agents; Cell Hypoxia; Cell Survival; Chromatography, High Pressure Liquid; Cyclooctanes; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Ginsenosides; Human Umbilical Vein Endothelial Cells; Humans; L-Lactate Dehydrogenase; Lignans; Malondialdehyde; Nitric Oxide; Polycyclic Compounds; Reactive Oxygen Species; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2015 |
An integrated pathway interaction network for the combination of four effective compounds from ShengMai preparations in the treatment of cardio-cerebral ischemic diseases.
Topics: Animals; Brain Ischemia; Cell Line; Cyclooctanes; Drug Combinations; Drugs, Chinese Herbal; Ginsenosides; Humans; Lignans; Myocardial Ischemia; NF-kappa B; Oxidative Stress; PC12 Cells; Polycyclic Compounds; Protein Interaction Maps; Rats; Saponins; Signal Transduction; Systems Biology; Tumor Necrosis Factor-alpha | 2015 |
The Effect of Schizandrol A-Induced DNA Methylation on SH-SY5YAB 1-40 Altered Neuronal Cell Line: A Potential Use in Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cell Line; Cell Survival; Cyclooctanes; DNA Methylation; Gene Expression Regulation; Humans; Lignans; Neurons; Peptide Fragments; Polycyclic Compounds; Real-Time Polymerase Chain Reaction; RNA, Messenger | 2015 |
Cardioprotection by combination of three compounds from ShengMai preparations in mice with myocardial ischemia/reperfusion injury through AMPK activation-mediated mitochondrial fission.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Cardiotonic Agents; Cyclooctanes; Drug Combinations; Drug Therapy, Combination; Drugs, Chinese Herbal; Dynamins; Ginsenosides; Lignans; Male; Mice, Inbred ICR; Mitochondrial Dynamics; Myocardial Reperfusion Injury; Polycyclic Compounds; Spirostans | 2016 |
Schisandra chinensis and Its Main Constituent Schizandrin Attenuate Allergic Reactions by Down-Regulating Caspase-1 in Ovalbumin-Sensitized Mice.
Topics: Animals; Caspase 1; Cyclooctanes; Down-Regulation; Hypersensitivity; Immunoglobulin E; Immunoglobulin G; Interleukin-1beta; Interleukin-4; Interleukin-6; Lignans; Mice; Ovalbumin; Plant Extracts; Polycyclic Compounds; Receptor-Interacting Protein Serine-Threonine Kinase 2; Receptor-Interacting Protein Serine-Threonine Kinases; Schisandra; Spleen; Tumor Necrosis Factor-alpha | 2017 |
Simultaneous determination of wogonin, oroxylin a, schisandrin, paeoniflorin and emodin in rat serum by HPLC-MS/MS and application to pharmacokinetic studies.
Topics: Animals; Chromatography, High Pressure Liquid; Cyclooctanes; Drugs, Chinese Herbal; Emodin; Female; Flavanones; Flavonoids; Glucosides; Lignans; Limit of Detection; Linear Models; Male; Monoterpenes; Polycyclic Compounds; Rats; Rats, Wistar; Reproducibility of Results; Tandem Mass Spectrometry | 2017 |
Study on the pharmacokinetics of deoxyschizandrin and schizandrin in combination with epigallocatechin gallate, a component of green tea, in rats.
Topics: Animals; Caco-2 Cells; Catechin; Cyclooctanes; Female; Humans; Lignans; Male; Polycyclic Compounds; Rats; Rats, Sprague-Dawley; Tea | 2018 |
Anti-inflammatory effects of a traditional Korean medicine: Ojayeonjonghwan.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Cyclooctanes; Cyclooxygenase 2; Cytokines; Dioxoles; Ethnopharmacology; Gene Expression Regulation; Lignans; Lipopolysaccharides; Macrophage Activation; Macrophages, Peritoneal; Male; Medicine, Korean Traditional; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Synthase Type II; Plant Extracts; Polycyclic Compounds; Prostatitis; Thioglycolates | 2017 |
A sensitive UHPLC-MS/MS method for the simultaneous quantification of three lignans in human plasma and its application to a pharmacokinetic study.
Topics: Chromatography, High Pressure Liquid; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Humans; Lignans; Polycyclic Compounds; Reproducibility of Results; Tandem Mass Spectrometry | 2017 |
Development and validation of an LC-MS/MS method for the simultaneous quantification of seven constituents in rat plasma and application in a pharmacokinetic study of the Zaoren Anshen prescription.
Topics: Animals; Benzaldehydes; Benzofurans; Catechols; Chromatography, Liquid; Cyclooctanes; Drug Stability; Drugs, Chinese Herbal; Flavonoids; Lignans; Limit of Detection; Linear Models; Male; Polycyclic Compounds; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tandem Mass Spectrometry | 2018 |
Schisandrin rescues depressive-like behaviors induced by chronic unpredictable mild stress via GDNF/ERK1/2/ROS and PI3K/AKT/NOX signaling pathways in mice.
Topics: Animals; Antidepressive Agents; Cyclooctanes; Depression; Glial Cell Line-Derived Neurotrophic Factor; Hippocampus; Lignans; Male; MAP Kinase Signaling System; Mice; NADPH Oxidases; Phosphatidylinositol 3-Kinases; Polycyclic Compounds; Prefrontal Cortex; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Stress, Psychological; Swimming | 2017 |
Schisandrin ameliorates cognitive impairment and attenuates Aβ deposition in APP/PS1 transgenic mice: involvement of adjusting neurotransmitters and their metabolite changes in the brain.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Cerebral Cortex; Chromatography, Liquid; Cognitive Dysfunction; Cyclooctanes; Female; Hippocampus; Lignans; Male; Maze Learning; Memory Disorders; Mice, Inbred C57BL; Mice, Transgenic; Neurotransmitter Agents; Nootropic Agents; Polycyclic Compounds; Presenilin-1; Tandem Mass Spectrometry | 2018 |
A Strategy for Optimizing the Combination of Active Components Based on Chinese Medicinal Formula Sheng-Mai-San for Myocardial Ischemia.
Topics: Animals; Creatine Kinase, MB Form; Cyclooctanes; Disease Models, Animal; Drug Combinations; Drugs, Chinese Herbal; Ginsenosides; Heart; Isoproterenol; L-Lactate Dehydrogenase; Lignans; Medicine, Chinese Traditional; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Pituitary Hormones, Posterior; Polycyclic Compounds; Spirostans; Troponin I | 2018 |
Synthesis and biological evaluation of Schizandrin derivatives as potential anti-cancer agents.
Topics: Antineoplastic Agents; Apoptosis; Binding Sites; Cell Cycle Checkpoints; Cell Line, Tumor; Cyclooctanes; Drug Screening Assays, Antitumor; G2 Phase; Humans; Inhibitory Concentration 50; Lignans; Molecular Docking Simulation; Polycyclic Compounds; Structure-Activity Relationship | 2018 |
Identifying quality-markers from Shengmai San protects against transgenic mouse model of Alzheimer's disease using chinmedomics approach.
Topics: Alzheimer Disease; Animals; Biomarkers, Pharmacological; Cyclooctanes; Dioxoles; Disease Models, Animal; Drug Combinations; Drugs, Chinese Herbal; Ginsenosides; Lignans; Male; Medicine, Chinese Traditional; Metabolomics; Mice, Transgenic; Neuroprotective Agents; Polycyclic Compounds | 2018 |
[Rapid identification of the different constituents in Fructus Schisandrae Chinensis before and after processing by UHPLC-QTOF/MS~E combining with metabonomics].
Topics: Chromatography, High Pressure Liquid; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Fruit; Lignans; Metabolomics; Polycyclic Compounds; Schisandra | 2016 |
[Analysis of lignans and their metabolites derived from Schisandra chinensis and vinegar Schisandra chinensis in rats’ plasma, bile, urine and faeces based on UHPLC-QTOF/MS].
Topics: Acetic Acid; Animals; Bile; Chromatography, High Pressure Liquid; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Feces; Lignans; Liver Diseases, Alcoholic; Plasma; Polycyclic Compounds; Rats; Schisandra; Urine | 2016 |
Protective effects of Schisandrin on high glucose-induced changes of RhoA and eNOS activity in human umbilical vein endothelial cells.
Topics: Cyclooctanes; Glucose; Human Umbilical Vein Endothelial Cells; Humans; Lignans; Nitric Oxide Synthase Type III; Polycyclic Compounds; rhoA GTP-Binding Protein | 2018 |
Simultaneous UPLC-MS/MS determination of four components of Socheongryong-tang tablet in human plasma: Application to pharmacokinetic study.
Topics: Administration, Oral; Adult; Chromatography, High Pressure Liquid; Cinnamates; Cyclooctanes; Drugs, Chinese Herbal; Ephedrine; Glucosides; Humans; Lignans; Linear Models; Male; Middle Aged; Monoterpenes; Polycyclic Compounds; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Young Adult | 2018 |
[Analysis of traditional Chinese medicine components by high performance liquid chromatography with diode array detection based on double qualitative principles].
Topics: Chromatography, High Pressure Liquid; Cyclooctanes; Drugs, Chinese Herbal; Lignans; Polycyclic Compounds | 2018 |
Effects of crushed Schisandra Fruit on the content of lignans in Kampo decoction.
Topics: Adult; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Female; Fruit; Humans; Lignans; Male; Medicine, Kampo; Polycyclic Compounds; Schisandra; Taste; Young Adult | 2019 |
Impact of dibenzocyclooctadiene lignans from Schisandra chinensis on the redox status and activation of human innate immune system cells.
Topics: B7-2 Antigen; Chlamydophila pneumoniae; Coculture Techniques; Cyclooctanes; Dendritic Cells; Gene Expression; Glutathione; HLA-DR Antigens; Humans; Immunologic Factors; Interleukin-10; Interleukin-12; Interleukin-6; Lignans; Lipopolysaccharides; Lymphocyte Activation; Oxidation-Reduction; Polycyclic Compounds; Primary Cell Culture; Reactive Oxygen Species; Schisandra; T-Lymphocytes; THP-1 Cells | 2019 |
Evaluation of neuroactive effects of ethanol extract of Schisandra chinensis, Schisandrin, and Schisandrin B and determination of underlying mechanisms by zebrafish behavioral profiling.
Topics: Animals; Behavior, Animal; Caenorhabditis elegans; Central Nervous System Agents; Cyclooctanes; Drugs, Chinese Herbal; Lignans; Plant Extracts; Polycyclic Compounds; Schisandra; Zebrafish | 2018 |
Chemical constituents isolated from stems of
Topics: Animals; Cyclooctanes; Dioxoles; Feeding Behavior; Lignans; Plant Stems; Polycyclic Compounds; Schisandra; Sesquiterpenes; Structure-Activity Relationship; Tribolium; Triterpenes | 2020 |
Schizandrol A reverses multidrug resistance in resistant chronic myeloid leukemia cells K562/A02.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Death; Cyclooctanes; Doxorubicin; Drug Resistance, Neoplasm; Humans; Intracellular Space; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lignans; Phosphorylation; Polycyclic Compounds; Proto-Oncogene Proteins c-akt; Rhodamine 123 | 2019 |
Schizandrin protects H9c2 cells against lipopolysaccharide-induced injury by downregulating Smad3.
Topics: Apoptosis; Cell Survival; Cyclooctanes; Cytokines; Down-Regulation; Humans; Lignans; Lipopolysaccharides; MAP Kinase Kinase 4; Myoblasts, Cardiac; NF-kappa B; Polycyclic Compounds; Schisandra; Signal Transduction; Smad3 Protein | 2019 |
Pharmacokinetics and liver uptake of three Schisandra lignans in rats after oral administration of liposome encapsulating β-cyclodextrin inclusion compound of Schisandra extract.
Topics: Administration, Oral; Animals; beta-Cyclodextrins; Biological Availability; Chromatography, High Pressure Liquid; Cyclooctanes; Drug Compounding; Lignans; Liposomes; Liver; Particle Size; Plant Extracts; Polycyclic Compounds; Rats, Wistar; Schisandra | 2019 |
An integrated strategy for ascertaining quality marker of Schisandra chinensis (Turcz.) Baill based on correlation analysis between depression-related monoaminergic metabolites and chemical components profiling.
Topics: Animals; Biomarkers; Chromatography, High Pressure Liquid; Cyclooctanes; Drugs, Chinese Herbal; Gas Chromatography-Mass Spectrometry; Lignans; Medicine, Chinese Traditional; Plants, Medicinal; Polycyclic Compounds; Quality Control; Rats; Schisandra; Tandem Mass Spectrometry | 2019 |
Combination of schisandrin and nootkatone exerts neuroprotective effect in Alzheimer's disease mice model.
Topics: Alzheimer Disease; Animals; Cyclooctanes; Disease Models, Animal; Glutathione; Lignans; Malondialdehyde; Maze Learning; Mice; Neuroprotective Agents; Oxidative Stress; Plant Extracts; Polycyclic Compounds; Polycyclic Sesquiterpenes; Superoxide Dismutase | 2019 |
Schizandrin Protects against OGD/R-Induced Neuronal Injury by Suppressing Autophagy: Involvement of the AMPK/mTOR Pathway.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Cyclooctanes; Disease Models, Animal; Glucose; Lignans; Mice; Models, Biological; Molecular Structure; Neurons; Neuroprotective Agents; Oxidation-Reduction; Oxygen; Polycyclic Compounds; Rats; Reperfusion Injury; Signal Transduction; Stroke; TOR Serine-Threonine Kinases | 2019 |
Assaying
Topics: Azithromycin; Biological Assay; Chlamydophila pneumoniae; Cyclooctanes; Glutathione; Humans; Kinetics; Lignans; Macrophages; Oxidation-Reduction; Phenotype; Polycyclic Compounds; Reactive Oxygen Species; THP-1 Cells | 2020 |
Schizandrin attenuates inflammation induced by avian pathogenic Escherichia coli in chicken type II pneumocytes.
Topics: Alveolar Epithelial Cells; Animals; Anti-Inflammatory Agents; Bacterial Adhesion; Cells, Cultured; Chickens; Cyclooctanes; Cytokines; Escherichia coli; Escherichia coli Infections; Extracellular Signal-Regulated MAP Kinases; Inflammation; Inflammation Mediators; L-Lactate Dehydrogenase; Lignans; NF-kappa B; Polycyclic Compounds; Poultry Diseases; Signal Transduction | 2020 |
Exploring the protective effects of schizandrol A in acute myocardial ischemia mice by comprehensive metabolomics profiling integrated with molecular mechanism studies.
Topics: Animals; Apoptosis; Cardiotonic Agents; Cell Line; Cyclooctanes; Enzymes; Lignans; Male; Metabolomics; Mice, Inbred ICR; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Polycyclic Compounds; Protein Interaction Maps; Rats; Signal Transduction | 2020 |
Synergistic neuroprotective effect of schisandrin and nootkatone on regulating inflammation, apoptosis and autophagy via the PI3K/AKT pathway.
Topics: Alzheimer Disease; Animals; Apoptosis; Autophagy; Cyclooctanes; Disease Models, Animal; Drug Synergism; Inflammation; Lignans; Mice; Neuroprotective Agents; PC12 Cells; Phosphatidylinositol 3-Kinases; Polycyclic Compounds; Polycyclic Sesquiterpenes; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; tau Proteins | 2020 |
Schisandrin ameliorates cognitive deficits, endoplasmic reticulum stress and neuroinflammation in streptozotocin (STZ)-induced Alzheimer's disease rats.
Topics: Alzheimer Disease; Animals; Cognition; Cognitive Dysfunction; Cyclooctanes; Disease Models, Animal; Endoplasmic Reticulum Stress; Lignans; Male; Phytotherapy; Polycyclic Compounds; Rats, Wistar; Schisandra; Sirtuin 1; Streptozocin; Up-Regulation | 2020 |
Study on the potential effective ingredients of Xiaosheng prescription for dry eye disease.
Topics: Animals; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Epithelium, Corneal; Female; Humans; Lignans; Mice; Plant Extracts; Polycyclic Compounds | 2020 |
Determination of 12 herbal compounds for estimating the presence of Angelica Gigas Root, Cornus Fruit, Licorice Root, Pueraria Root, and Schisandra Fruit in foods by LC-MS/MS.
Topics: Benzopyrans; Butyrates; Chromatography, Liquid; Coumarins; Cyclooctanes; Dioxoles; Flavanones; Food Analysis; Fruit; Glucosides; Glycosides; Glycyrrhizic Acid; Herbal Medicine; Iridoids; Isoflavones; Lignans; Plant Roots; Plants, Medicinal; Polycyclic Compounds; Tandem Mass Spectrometry | 2020 |
Effect of roasting temperature and time on volatile compounds, total polyphenols, total flavonoids, and lignan of omija (Schisandra chinensis Baillon) fruit extract.
Topics: Cooking; Cyclooctanes; Dioxoles; Flavonoids; Fruit; Lignans; Plant Extracts; Polycyclic Compounds; Polyphenols; Schisandra; Temperature; Volatile Organic Compounds | 2021 |
Mechanisms dissection of the combination GRS derived from ShengMai preparations for the treatment of myocardial ischemia/reperfusion injury.
Topics: Animals; Cell Line; Cell Survival; Cyclooctanes; Drug Combinations; Drugs, Chinese Herbal; Ginsenosides; Inflammation Mediators; Lignans; Male; Mice; Mice, Inbred ICR; Myocardial Reperfusion Injury; Myocytes, Cardiac; Polycyclic Compounds; Rats; Spirostans; Treatment Outcome | 2021 |
Antidepressant-like effects of Schisandrin on lipopolysaccharide-induced mice : Gut microbiota, short chain fatty acid and TLR4/NF-κB signaling pathway.
Topics: Animals; Anti-Inflammatory Agents; Antidepressive Agents; Bacteria; Behavior, Animal; Cyclooctanes; Cytokines; Depression; Disease Models, Animal; Dysbiosis; Fatty Acids, Volatile; Gastrointestinal Microbiome; Hippocampus; Host-Pathogen Interactions; Inflammation Mediators; Lignans; Lipopolysaccharides; Male; Mice, Inbred C57BL; Motor Activity; NF-kappa B; Polycyclic Compounds; Signal Transduction; Toll-Like Receptor 4 | 2020 |
Impact of volatile oils from processed products of Schisandra chinensis fruits on a mouse model of allergic asthma.
Topics: Animals; Asthma; Cyclooctanes; Fruit; Hypersensitivity; Lignans; Male; Mice; Oils, Volatile; Ovalbumin; Plant Extracts; Polycyclic Compounds; Schisandra | 2020 |
Schisandrin Restores the Amyloid β-Induced Impairments on Mitochondrial Function, Energy Metabolism, Biogenesis, and Dynamics in Rat Primary Hippocampal Neurons.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Newborn; Cyclooctanes; Cytochromes c; Energy Metabolism; Hippocampus; Lignans; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Dynamics; Models, Biological; Neurons; Neuroprotective Agents; Organelle Biogenesis; Peptide Fragments; Polycyclic Compounds; Primary Cell Culture; Rats, Sprague-Dawley | 2021 |
Pharmacokinetic study of Ninjin'yoeito: Absorption and brain distribution of Ninjin'yoeito ingredients in mice.
Topics: Administration, Oral; Animals; Brain; Chromatography, Liquid; Cyclooctanes; Drugs, Chinese Herbal; Lignans; Male; Mass Spectrometry; Mice; Mice, Inbred C57BL; Polycyclic Compounds; Tissue Distribution | 2021 |
Schisandrin improves lipopolysaccharide-induced acute lung injury by inhibiting the inflammatory response in vivo and in vitro.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Cyclooctanes; Lignans; Lipopolysaccharides; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Polycyclic Compounds; Sepsis | 2022 |
Examination of the Impact of CYP3A4/5 on Drug-Drug Interaction between Schizandrol A/Schizandrol B and Tacrolimus (FK-506): A Physiologically Based Pharmacokinetic Modeling Approach.
Topics: Cyclooctanes; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dioxoles; Drug Interactions; Humans; Immunosuppressive Agents; Lignans; Models, Biological; Polycyclic Compounds; Tacrolimus | 2022 |
A multidimensional strategy for uncovering comprehensive quality markers of Schisandra chinensis (Turcz.) Baill based on pharmacodynamics and chemical properties.
Topics: Animals; Biomarkers; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Lignans; Polycyclic Compounds; Rats; Schisandra | 2022 |
Schisandra B, a representative lignan from Schisandra chinensis, improves cisplatin-induced toxicity: An in vitro study.
Topics: Animals; Cisplatin; Glutathione; Inflammation; Lignans; NF-kappa B; Oxidative Stress; Phosphatidylinositol 3-Kinases; Rats; Schisandra | 2023 |
Anti-adiposity and lipid-lowering effects of schisandrol A in diet-induced obese mice.
Topics: Animals; Diet, High-Fat; Lignans; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; RNA, Messenger | 2022 |
Bioactive compounds from Schisandra chinensis - Risk for aquatic plants?
Topics: Ecosystem; Humans; Lignans; Schisandra; Water; Water Pollutants, Chemical | 2023 |
Dimethylbutyrylated Dibenzocyclooctadiene Lignans from the Fruits of Schisandra cauliflora Inhibit NO Production in LPS-Activated RAW264.7 Cells.
Topics: Cyclooctanes; Fruit; Lignans; Lipopolysaccharides; Molecular Structure; Schisandra | 2023 |
Four new lignans obtained from the leaves of Schisandra cauliflora and their effect on skeletal muscle cell proliferation.
Topics: Cell Proliferation; Lignans; Muscle, Skeletal; Plant Leaves; Schisandra | 2023 |
Inhibitory effects of Schisandrin C on collagen behavior in pulmonary fibrosis.
Topics: Animals; Collagen; Lignans; Mice; Polycyclic Compounds; Pulmonary Fibrosis | 2023 |
Effects of schisandra lignans on the absorption of protopanaxadiol-type ginsenosides mediated by P-glycoprotein and protopanaxatriol-type ginsenosides mediated by CYP3A4.
Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP3A; Ginsenosides; Lignans; Molecular Docking Simulation; Plant Extracts; Schisandra | 2024 |
Analysis of Volatile Components in Dried Fruits and Branch Exudates of
Topics: Fruit; Lignans; Plant Extracts; Schisandra | 2023 |